Anest. intenziv. Med. 2021;32(2):109-110

What the blood count hidesShort Communication

Harazim M.1, 3, Chvojka J.2, 3
1 Jednotka intenzivní péče, Interní gastroenterologická klinika Fakultní nemocnice Brno
2 Jednotka intenzivní péče, I. interní klinika Fakultní nemocnice Plzeň
3 Lékařská fakulta v Plzni Univerzity Karlovy v Praze

Published: April 29, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Harazim M, Chvojka J. What the blood count hides. Anest. intenziv. Med. 2021;32(2):109-110.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent J‑L. Biomarkers of sepsis: time for a reappraisal. Critical Care. 2020; 24(1): 1-15. Go to original source... Go to PubMed...
    2. Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001; 102(1): 5-14. Go to PubMed...
    3. Ljungström L, Pernestig A‑K, Jacobsson G, Andersson R, Usener B, Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil‑lymphocyte count ratio, C‑reactive protein, and lactate in patients with suspected bacterial sepsis. PloS one. 2017; 12(7): e0181704. Go to original source... Go to PubMed...
    4. Jeon TJ, Park JY. Clinical significance of the neutrophil‑lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis. World journal of gastroenterology. 2017; 23(21): 3883. Go to original source... Go to PubMed...
    5. Karataş MB, İpek G, Onuk T, Güngör B, Durmuş G, Çanga Y, et al. Assessment of prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with pulmonary embolism. Acta Cardiologica Sinica. 2016; 32(3): 313. Go to PubMed...
    6. Bastug A, Bodur H, Erdogan S, Gokcinar D, Kazancioglu S, Kosovali BD, et al. Clinical and laboratory features of COVID-19: Predictors of severe prognosis. International immunopharmacology. 2020; 88: 106950. Go to original source... Go to PubMed...
    7. Farkas J. PulmCrit: Neutrophil‑Lymphocyte Ratio (NLR): Free upgrade to your WBC 2019. Dostupné z: https://emcrit.org/pulmcrit/nlr/.
    8. Zhang J, Zhang H‑Y, Li J, Shao X‑Y, Zhang C‑X. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta‑analysis. Oncotarget. 2017; 8(40): 68837. Go to original source... Go to PubMed...
    9. Wu Y, Chen Y, Yang X, Chen L, Yang Y. Neutrophil‑to‑lymphocyte ratio (NLR) and platelet‑to‑lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. International immunopharmacology. 2016; 36: 94-99. Go to original source... Go to PubMed...
    10. Phan TT, Ho TT, Nguyen HT, Tran TB, Nguyen ST. The prognostic impact of neutrophil to lymphocyte ratio in advanced non‑small cell lung cancer patients treated with EGFR TKI. Int J Gen Med. 2018; 11: 423-430. Go to original source... Go to PubMed...
    11. Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H, et al. Platelet‑to‑lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PloS one. 2013; 8(7): e67688. Go to original source... Go to PubMed...
    12. Merekoulias G, Alexopoulos EC, Belezos T, Panagiotopoulou E, Jelastopulu DM. Lymphocyte to monocyte ratio as a screening tool for influenza. PLoS Curr. 2010; 2: Rrn1154. Go to original source... Go to PubMed...
    13. Peng J, Qi D, Yuan G, Deng X, Mei Y, Feng L, et al. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross‑sectional study. J Clin Lab Anal. 2020: e23475. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.